BioArctic AB (publ) (BIOA-B) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.021x

Based on the latest financial reports, BioArctic AB (publ) (BIOA-B) has a cash flow conversion efficiency ratio of -0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-41.19 Million ≈ $-4.43 Million USD) by net assets (Skr1.97 Billion ≈ $211.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

BioArctic AB (publ) - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how BioArctic AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of BioArctic AB (publ) for a breakdown of total debt and financial obligations.

BioArctic AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioArctic AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Konecranes Plc HE:KCR	0.066x
GOLDEN AGRI-RES ADR/100 F:4G3	N/A
Zhuhai Bojay Electronics Co Ltd SHE:002975	0.010x
ViTrox Corporation Bhd KLSE:0097	-0.023x
Brightstar Lottery PLC NYSE:BRSL	-0.342x
Energisa S.A SA:ENGI3	0.056x
Hyosung Corp KO:004800	0.024x
Sai Gon Ha Noi Commercial Joint Stock Bank VN:SHB	0.413x

Annual Cash Flow Conversion Efficiency for BioArctic AB (publ) (2015–2024)

The table below shows the annual cash flow conversion efficiency of BioArctic AB (publ) from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see BIOA-B market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr894.94 Million ≈ $96.31 Million	Skr-316.33 Million ≈ $-34.04 Million	-0.353x	-219.45%
2023-12-31	Skr1.05 Billion ≈ $112.63 Million	Skr309.69 Million ≈ $33.33 Million	0.296x	+835.38%
2022-12-31	Skr786.24 Million ≈ $84.61 Million	Skr-31.64 Million ≈ $-3.40 Million	-0.040x	+77.41%
2021-12-31	Skr788.68 Million ≈ $84.87 Million	Skr-140.46 Million ≈ $-15.12 Million	-0.178x	-74.98%
2020-12-31	Skr907.30 Million ≈ $97.64 Million	Skr-92.34 Million ≈ $-9.94 Million	-0.102x	-130.32%
2019-12-31	Skr974.50 Million ≈ $104.87 Million	Skr327.17 Million ≈ $35.21 Million	0.336x	+270.79%
2018-12-31	Skr1.02 Billion ≈ $109.52 Million	Skr-200.06 Million ≈ $-21.53 Million	-0.197x	+7.60%
2017-12-31	Skr636.13 Million ≈ $68.46 Million	Skr-135.33 Million ≈ $-14.56 Million	-0.213x	-101.91%
2016-12-31	Skr60.76 Million ≈ $6.54 Million	Skr675.13 Million ≈ $72.65 Million	11.111x	+7421.42%
2015-12-31	Skr108.28 Million ≈ $11.65 Million	Skr-16.43 Million ≈ $-1.77 Million	-0.152x	--

About BioArctic AB (publ)

ST:BIOA-B Sweden Biotechnology

Market Cap

$2.59 Billion

Skr24.04 Billion SEK

Market Cap Rank

#5393 Global

#71 in Sweden

Share Price

Skr323.80

Change (1 day)

+1.76%

52-Week Range

Skr172.00 - Skr364.40

All Time High

Skr377.80